Cannabis

EXPLORE

Profile Image
Dana A. Kravetz
Firm Managing Partner
TELEPHONE NUMBER
310-299-5500
EMAIL ADDRESS
[email protected]

Overview

Legalized marijuana – be it for medical or recreational use – is here and the business is booming. Cannabis in all its forms, including CBD, is a multi-billion-dollar industry that’s taken the marketplace by storm and only shows signs of continued growth, as more and more states turn green and the federal law shows signs of following suit.

We’ve watched the legalization debate for years and continue to monitor the long-term viability of the Controlled Substances Act (CSA), the law that renders the medical and recreational use of cannabis illegal on the federal level. The CSA aside, we embrace the acceptance, regulation and ongoing commercialization of marijuana in the ever-expanding list of jurisdictions that have legalized it and have built a practice around the industry. We’ve done so with the understanding that while players in the cannabis space are confronted with a unique set of regulatory challenges, they’re also subject to the same operational issues prevalent across industries.

With that in mind, the cannabis attorneys at M&R take pride in their representation of marijuana-related businesses (e.g., retailers, wholesalers, processors, growers, distributors, licensees/licensors, investors and ancillary concerns) and those promoting social equity within the cannabis sector.

Areas of Expertise

Commercial Litigation
Corporate Law (including entity formation)
Employment Law (including wage & hour issues)
Intellectual Property
Outside General Counsel (handling day-to-day administrative and operational matters, including contracts)
Real Estate Law (including leasing and acquisitions)
Regulatory Law and Compliance

Representative Matters

There is no corresponding news at this time.

There is no corresponding news at this time.

There is no corresponding news at this time.

There is no corresponding news at this time.

There is no corresponding news at this time.

There is no corresponding news at this time.

There is no corresponding news at this time.